Burning Rock Biotech earnings were -$59.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest BNR earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$5.0M, down 66.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, BNR reported annual earnings of -$92.2M, with -33.8% growth.
Burning Rock Biotech Earnings Reports & History FAQ
What were Burning Rock Biotech's earnings last quarter?
On BNR's earnings call on Invalid Date, Burning Rock Biotech (NASDAQ: BNR) reported Q3 2024 earnings per share (EPS) of -$0.49, up 79.08% year over year. Total BNR earnings for the quarter were -$5.02 million. In the same quarter last year, Burning Rock Biotech's earnings per share (EPS) was -$2.35.
Is Burning Rock Biotech profitable or losing money?
As of the last Burning Rock Biotech earnings report, Burning Rock Biotech is currently losing money. Burning Rock Biotech's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$60.05 million, a 38.31% decrease year over year.
What was BNR's earnings growth in the past year?
As of Burning Rock Biotech's earnings date in Invalid Date, Burning Rock Biotech's earnings has grown year over year. BNR earnings in the past year totalled -$58.97 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.